Biomedical Frontiers: Stories with Innovators in Healthcare

by Dasha Tyshlek

Welcome to 'Biomedical Frontiers: Stories with Innovators in Healthcare,' a podcast produced by the University of Virginia's Wallace H. Coulter Center for Translational Research.

Biomedical Frontiers is a forum for in-depth discussions at the intersection of healthcare technology and translational research. We feature leading voices from the University of Virginia community and the broader biomedical industry. Each epi ... 

 ...  Read more

Podcast episodes

  • Season 1

  • Dr. Slivia Blemker on Modeling Muscles with MRI and AI for Personalized Musculoskeletal Healthcare

    Dr. Slivia Blemker on Modeling Muscles with MRI and AI for Personalized Musculoskeletal Healthcare

    Muscles play a pivotal role throughout our bodies, not just in our day-to-day functions but also as foundational elements in our journey towards healthy aging. At the forefront of exploring this intricate system is Dr. Silvia Blemker and her dedicated team at the M3 Lab at the University of Virginia. Their innovative approach weaves together advanced imaging, hands-on experimentation, and sophisticated computational methods to delve deep into the anatomy and mechanics of muscles, shedding light on various muscle-related diseases. Through her venture, Springbok Analytics, Dr. Blemker is revolutionizing the way we understand muscle health. By harnessing the power of Artificial Intelligence (AI) and merging it with the precision of MRI technology, her team is crafting real-time, detailed models of muscles. This breakthrough initiative is not just about enhancing athletic performance or speeding up recovery but is also a key player in the prevention of muscle diseases. In the latest installment of Biomedical Frontiers: Stories with Innovators in Healthcare, Dr. Blemker takes us on a journey through the evolution of Biomedical Engineering as a discipline. She shares her approach to leveraging AI to accelerate the pace of developing Springboks Analytics technologies for more applications. Dr. Blemker also introduces us to one of her groundbreaking projects, funded by the NIH, aimed at developing precise, sex-specific musculature models.This project promises to equip future researchers with robust tools for studying women's muscle systems with unparalleled accuracy, ensuring that gender disparities in medical research are addressed head-on. Follow Dr. Blemker on Social Media LinkedIn: https://www.linkedin.com/in/silvia-blemker/ Twitter: https://twitter.com/UvaM3Lab M3 Lab: http://www.uvam3lab.com/ Learn about Springbok Analytics: https://www.springbokanalytics.com/ To enroll in the study for developing a computational method that will be able to accurately examine how sex differences in muscles and bones influence the lower limbs during movement reach out to Dr. Silvia Blemker at ssblemker@virginia.edu or fill out this form: https://virginia.az1.qualtrics.com/jfe/form/SV_bEFhlTljsxcAEUm Director & Host: Dasha Tyshlek, StratCraft, Inc. www.strat-craft.com Executive Producer: David Chen, Managing Director & Instructor of Engineering Design, UVA Senior Producer: Hannah Moore, Associate Director, UVA Coulter Design Director: Carolyn Wagner, Inc. & Link: carolynwagnerinc.com Produced on behalf of Wallace H. Coulter Center for Translational Research at University of Virginia https://engineering.virginia.edu/research/centers-institutes/coulter

  • Dr. Natasha Sheybani on Precision Cancer Treatments with Immunotherapy and Focused Ultrasound

    Dr. Natasha Sheybani on Precision Cancer Treatments with Immunotherapy and Focused Ultrasound

    An in-depth discussion with Dr. Natasha Sheybani, who is pioneering the use of Focused Ultrasound (FUS) in precision cancer treatment at the University of Virginia. Dr. Sheybani's research focuses on enhancing immunotherapy for brain and breast cancers through innovative, non-invasive techniques. Her efforts to improve glioblastoma patient outcomes by overcoming major treatment barriers, such as the blood-brain barrier, have earned her recognition by the Forbes 30 under 30 in Science Award and many others. This episode delves into the promising future of cancer care, highlighting the collaborative efforts and clinical trials underway at UVA that are bringing us closer to more effective, personalized cancer treatments. -------------- Follow Dr. Sheybani on Social Media: Twitter: https://x.com/ndsheybani?s=20 LinkedIn: https://www.linkedin.com/in/natasha-sheybani-024439123/ Learn about the FUS Cancer Immunotherapy Center: https://med.virginia.edu/uva-focused-ultrasound-cancer-immunotherapy-center/ Director & Host: Dasha Tyshlek, StratCraft, Inc. www.strat-craft.com Executive Producer: David Chen, Managing Director & Instructor of Engineering Design, UVA Senior Producer: Hannah Moore, Associate Director, UVA Coulter Design Director: Carolyn Wagner, Inc. & Link: carolynwagnerinc.com Produced on behalf of Wallace H. Coulter Center for Translational Research at University of Virginia https://engineering.virginia.edu/research/centers-institutes/coulter

  • Dr. Nathan Price on Alzheimers, Digital Twins, and the Future of Medicine in the Age of AI

    Dr. Nathan Price on Alzheimers, Digital Twins, and the Future of Medicine in the Age of AI

    In this episode we delve into the future of medicine with Dr. Nathan Price, Chief Science Officer at Thorne HealthTech and co-author of "The Age of Scientific Wellness." Dr. Price shares his visionary insights on the transformation of medicine through systems biology approaches, modeling and analytics, and practices centered in prevention. He shares how his research uses digital twins in predicting and preventing the progression of Alzheimer’s diseases and how other AI developments are impacting access to diagnosis and treatments. Dr. Nathan Price highlights the transformative power of combining phenotyping and genotyping in research, allowing for a deeper understanding of disease progression and potential interventions long before symptoms appear. “You can look for what's different in individuals 20 years before the disease would be expected to emerge. What you find is that there are differences that are manifested in the blood in these dense data clouds. This longitudinal data is different as a function of differential risk for that disease.” At University of Virginia Dr. Price evaluates and guides promising translational research projects through his role on the board of the Coulter Translational Research Center. Follow Dr. Price on Social Media: LinkedIn: https://www.linkedin.com/in/nathandprice/ Twitter: https://x.com/ISBNathanPrice?s=20 Read his new book “The Age of Scientific Wellness: Why the Future of Medicine is Personalized, Predictive, Data Rich and In Your Hands https://www.hup.harvard.edu/books/9780674245945 Learn more about Thorne HealthTech: https://www.thorne.com/ Director & Host: Dasha Tyshlek, StratCraft, Inc. www.strat-craft.com Executive Producer: David Chen, Managing Director & Instructor of Engineering Design, UVA Senior Producer: Hannah Moore, Associate Director, UVA Coulter Design Director: Carolyn Wagner, Inc. & Link: carolynwagnerinc.com Produced on behalf of Wallace H. Coulter Center for Translational Research at University of Virginia https://engineering.virginia.edu/research/centers-institutes/coulter